E Fund Management Co., Ltd. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$175,000
-27.7%
41,391
-52.2%
0.02%
-27.3%
Q2 2022$242,000
-11.4%
86,581
+81.3%
0.02%
+144.4%
Q1 2022$273,000
+62.5%
47,763
+160.0%
0.01%
+50.0%
Q4 2021$168,000
+6.3%
18,367
+24.1%
0.01%
-14.3%
Q3 2021$158,00014,8050.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders